We are live on
!
Find out more
Bioventus
BVS
BVS
80 hedge funds and large institutions have $176M invested in Bioventus in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
144% more call options, than puts
Call options by funds: $1.03M | Put options by funds: $421K
108% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 12
62% more capital invested
Capital invested by funds: $109M → $176M (+$67.6M)
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
19% more funds holding
Funds holding: 67 → 80 (+13)
0.62% more ownership
Funds ownership: 52.55% → 53.18% (+0.62%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
80
Holders Change
+13
Holders Change %
+19.4%
% of All Funds
1.17%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
25
Increased
25
Reduced
17
Closed
12
Calls
$1.03M
Puts
$421K
Net Calls
+$607K
Net Calls Change
+$219K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.49M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$613K |
| 3 |
Jane Street
New York
|
+$492K |
| 4 |
LCM
Laurion Capital Management
New York
|
+$468K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$344K |
Top Sellers
| 1 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$1.99M |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$929K |
| 3 |
Millennium Management
New York
|
-$414K |
| 4 |
Bank of New York Mellon
New York
|
-$306K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$294K |
